drugset / Trial / NCT05921968

Effect of Lactoferrin Versus Intravenous Iron Sucrose in Treatment of Anemia

NCT05921968

Phase 4 Unknown 100 enrolled Ain Shams University
RandomizedParallel-groupOpen-labelTreatment

Summary

Iron deficiency is the most common nutritional deficiency and the most common cause of anemia. Anemia has a significant impact on the health of the fetus as well as that of the mother. It impairs the oxygen delivery through the placenta to the fetus and interferes with the normal intrauterine growth, leading to fetal loss and perinatal deaths. Anemia is associated with increased preterm labor (28.2%), preeclampsia (31.2%), and maternal sepsis. The study aims to compare the effect of Lactoferrin versus intravenous iron sucrose for the treatment of iron deficiency anemia during pregnancy.

Timeline

Start
2023-07-30
Primary completion
2024-01-01
Completion
2024-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Iron sucrose Unknown 200 mg Intravenous
Comparator Lactoferrin Protein / enzyme biologic 100 mg Oral